These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8121888)

  • 21. Precautions in handling tissues, fluids, and other contaminated materials from patients with documented or suspected Creutzfeldt-Jakob disease. Committee on Health Care Issues, American Neurological Association.
    Ann Neurol; 1986 Jan; 19(1):75-7. PubMed ID: 3511838
    [No Abstract]   [Full Text] [Related]  

  • 22. [Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part I].
    Zaborowski A
    Psychiatr Pol; 2004; 38(2):283-96. PubMed ID: 15307293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.
    Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M
    Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Creutzfeldt Jakob disease. Recommended precautions for patient management and diagnostic procedures (author's transl)].
    Brown P; Cathala F; Gajdusek DC
    Rev Neurol (Paris); 1978 Apr; 134(4):277-86. PubMed ID: 364589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current strategies to prevent transmission of prions by human plasma derivatives.
    Burnouf T; Padilla A
    Transfus Clin Biol; 2006 Nov; 13(5):320-8. PubMed ID: 17254822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dental practice implications of prion diseases.
    Bebermeyer RD; Powell JF; Hobdell MH; Durban EM
    Quintessence Int; 2003 Jan; 34(1):38-44. PubMed ID: 12674357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Guidelines for autopsy findings and handling of tissues of subjects with probable or certain Creutzfeldt-Jacob disease or other prion diseases. Italian Society of Pathologic Anatomy and Diagnostic Cytopathology].
    Pathologica; 1996 Aug; 88(4):328-30. PubMed ID: 9005404
    [No Abstract]   [Full Text] [Related]  

  • 28. Alcoholic fixation of blood to surgical instruments-a possible factor in the surgical transmission of CJD?
    Prior F; Fernie K; Renfrew A; Heneaghan G
    J Hosp Infect; 2004 Sep; 58(1):78-80. PubMed ID: 15350717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BSE: can we predict the future?
    Plum J
    Bull Mem Acad R Med Belg; 1997; 152(6):264-73. PubMed ID: 9581370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How to limit the spread of Creutzfeldt-Jakob disease.
    Dormont D
    Infect Control Hosp Epidemiol; 1996 Aug; 17(8):521-8. PubMed ID: 8875297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The human prion diseases. A review with special emphasis on new variant CJD and comments on surveillance.
    Keohane C
    Clin Exp Pathol; 1999; 47(3-4):125-32. PubMed ID: 10472732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perioperative considerations for performing a brain biopsy on a patient with subtype VV2 sporadic Creutzfeldt-Jakob disease.
    Guerrero-Domínguez R; Rubio-Romero R; González-González G; Jiménez I
    Rev Esp Anestesiol Reanim; 2015 Apr; 62(4):213-7. PubMed ID: 25146772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 'high-risk' neuropathological autopsy in AIDS and Creutzfeldt-Jakob disease: principles and practice.
    Ironside JW; Bell JE
    Neuropathol Appl Neurobiol; 1996 Oct; 22(5):388-93. PubMed ID: 8930948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consensus statement on the bio-safety of urinary-derived gonadotrophins with respect to Creutzfeldt-Jakob disease.
    Balen AH; Lumholtz IB
    Hum Reprod; 2005 Nov; 20(11):2994-9. PubMed ID: 16055457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prion diseases of humans and farm animals: epidemiology, genetics, and pathogenesis.
    Aguzzi A
    J Neurochem; 2006 Jun; 97(6):1726-39. PubMed ID: 16805779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative studies on the thermostability of five strains of transmissible-spongiform-encephalopathy agent.
    Fernie K; Steele PJ; Taylor DM; Somerville RA
    Biotechnol Appl Biochem; 2007 Aug; 47(Pt 4):175-83. PubMed ID: 17331068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human prion diseases.
    Thakur R; Vincent YM; Chaturvedi S
    Natl Med J India; 2002; 15(6):339-45. PubMed ID: 12540068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The spread of prions through the body in naturally acquired transmissible spongiform encephalopathies.
    Beekes M; McBride PA
    FEBS J; 2007 Feb; 274(3):588-605. PubMed ID: 17288548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Creutzfeldt-Jakob disease in Austria: an autopsy-controlled study.
    Gelpi E; Heinzl H; Hoftberger R; Unterberger U; Strobel T; Voigtlander T; Drobna E; Jarius C; Lang S; Waldhor T; Bernheimer H; Budka H
    Neuroepidemiology; 2008; 30(4):215-21. PubMed ID: 18424902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prion inactivation and medical instrument reprocessing: challenges facing healthcare facilities.
    Sehulster LM
    Infect Control Hosp Epidemiol; 2004 Apr; 25(4):276-9. PubMed ID: 15108722
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.